These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 24360801)
1. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies. Leufkens TR; Vermeeren A Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801 [TBL] [Abstract][Full Text] [Related]
2. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo. Leufkens TR; Vermeeren A J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642 [TBL] [Abstract][Full Text] [Related]
3. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. Leufkens TR; Lund JS; Vermeeren A J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733 [TBL] [Abstract][Full Text] [Related]
4. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Vermeeren A; Riedel WJ; van Boxtel MP; Darwish M; Paty I; Patat A Sleep; 2002 Mar; 25(2):224-31. PubMed ID: 11905433 [TBL] [Abstract][Full Text] [Related]
5. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers. Farber RH; Burke PJ Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978 [TBL] [Abstract][Full Text] [Related]
6. Individual psychomotor impairment in relation to zopiclone and ethanol concentrations in blood--a randomized controlled double-blinded trial. Gustavsen I; Hjelmeland K; Bernard JP; Mørland J Addiction; 2012 May; 107(5):925-32. PubMed ID: 22008377 [TBL] [Abstract][Full Text] [Related]
7. A method to assess the dissipation of the [corrected] residual effects of [corrected] hypnotics: eszopiclone versus zopiclone. Boyle J; Groeger JA; Paska W; Cooper JA; Rockett C; Jones S; Gandhi P; Scott J; Atzori G; Dijk DJ J Clin Psychopharmacol; 2012 Oct; 32(5):704-9. PubMed ID: 22926608 [TBL] [Abstract][Full Text] [Related]
8. Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability. Verster JC; Spence DW; Shahid A; Pandi-Perumal SR; Roth T Curr Drug Saf; 2011 Sep; 6(4):209-18. PubMed ID: 22129315 [TBL] [Abstract][Full Text] [Related]
9. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study. Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A Psychopharmacology (Berl); 2014 Jul; 231(14):2785-98. PubMed ID: 24458443 [TBL] [Abstract][Full Text] [Related]
10. Can a simple clinical test detect impairment of zopiclone and alcohol? - A randomized controlled trial. Hjelmeland K; Gustavsen I; Bernard JP; Mørland J Forensic Sci Int; 2015 Mar; 248():129-33. PubMed ID: 25617762 [TBL] [Abstract][Full Text] [Related]
11. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use. Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571 [TBL] [Abstract][Full Text] [Related]
12. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. Boyle J; Trick L; Johnsen S; Roach J; Rubens R Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566 [TBL] [Abstract][Full Text] [Related]
13. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064 [TBL] [Abstract][Full Text] [Related]
14. Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study. Meskali M; Berthelon C; Marie S; Denise P; Bocca ML Psychopharmacology (Berl); 2009 Dec; 207(3):461-7. PubMed ID: 19798483 [TBL] [Abstract][Full Text] [Related]
15. Psychomotor performance after intake of zopiclone compared with intake of ethanol: a randomized, controlled, double-blinded trial. Gustavsen I; Hjelmeland K; Bernard JP; Mørland J J Clin Psychopharmacol; 2011 Aug; 31(4):481-8. PubMed ID: 21694628 [TBL] [Abstract][Full Text] [Related]
16. A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers. Lader M; Denney SC Int Pharmacopsychiatry; 1982; 17 Suppl 2():98-108. PubMed ID: 7188379 [TBL] [Abstract][Full Text] [Related]
17. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly. Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295 [TBL] [Abstract][Full Text] [Related]
18. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers. Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life. Roth T; Eklov SD; Drake CL; Verster JC Traffic Inj Prev; 2014; 15(5):439-45. PubMed ID: 24678565 [TBL] [Abstract][Full Text] [Related]
20. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Staner L; Ertlé S; Boeijinga P; Rinaudo G; Arnal MA; Muzet A; Luthringer R Psychopharmacology (Berl); 2005 Oct; 181(4):790-8. PubMed ID: 16025317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]